Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
25.09.25
/
50%
€83.00
Target price
25.09.26
-
Performance (%)
-10.84%
Price
17.04.26
€74.00
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.84%. This prediction currently runs until 25.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 3.497% | 3.497% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.94
17.03.27
17.03.27
-2.58%
17.04.26
17.04.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€93.00
27.11.25
27.11.25
€117.12
27.11.26
27.11.26
-18.82%
17.04.26
17.04.26